TEST:

LENA Q51®

"ALERCELL, INC. announced...that it has introduced a new Research Use Only (RUO) LENA Q51® Leukemia diagnostic test for commercial sale. Lena Q51® was developed to detect up to 51 genes mutations associated with Leukemia...The RUO LENA Q51® will be available while the company completes clinical trials and regulatory submissions to support U.S. Food and Drug Administration (FDA) approval for broader clinical use."

"Alercell is all set to launch LENA Q51® in January 2023. A leukemia diagnostic test based on sequencing DNA will detect up to 51 Genes mutations in Leukemia patients...LENA Q51® will be introduced as a RUO not for diagnostic purpose to selected cancer institutes and universities to start with."